Generics - Biosimilars


Current filters:


Popular Filters

1240 to 1264 of 1269 results

Israeli generics giant Teva wins largest share of German health insurance AOK tenders


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s biggest generic drugmaker,…

EuropeGenericsMarkets & MarketingTeva Pharmaceutical Industries

US Medicare likely to run out of funds in 2024; Congressional Affordable Medicines Caucus


The US Trustees of the Social Security and Medicare trust funds report on the current and projected financial…

GenericsHealthcareNorth AmericaPharmaceuticalPoliticsPricing

Dr Reddy’s launches Neulastim copy in India; doubles 4th-qtr profit


Hyderabad, India-based generic drugmaker Dr Reddy’s Laboratories (NYSE: RDY) has launched its Peg-grafeel,…

Asia-PacificDr Reddy's LaboratoriesFinancialGenericsMarkets & MarketingNeulastimOncologyPeg-grafeelRoche

Australia clears way for increased access to generic medicines


Australian consumers and health professionals will have more ready access to generic medicines following…


Teva 1st-qrt 2011 financials boosted by strong European sales


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s leading generics firm, reported…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Ranbaxy 1st-qtr 2011 net profit plunges 68% and sales fall 12%


India’s largest drugmaker, Ranbaxy Laboratories RANB: BO), which is 64% owned by Japan’s Daiichi…

FinancialGenericsRanbaxy Laboratories

US FDA consults on user fee program for biosimilar and interchangeable biologicals


The US Food and Drug Administration is requesting input from stakeholders and the public relating to…

BiotechnologyGenericsNorth AmericaPharmaceuticalRegulation

India set to become global leader in APIs industry


Low-cost manufacturing facilities and abundant talent pool will drive the growth of India in the global…

Asia-PacificGenericsMarkets & Marketing

Growth in Canadian drug spending slows to lowest rate since 1996


Although drugs remain an important cost driver in Canada’s health system, growth in spending has…

GenericsHealthcareNorth AmericaPharmaceuticalPricing

Nigerian government plans local production of anti-malaria drugs


To further reduce the cost of anti-malaria drug and reduce malaria incidence to the barest minimum, the…

GenericsMarkets & MarketingPharmaceuticalPoliticsRest of the WorldTropical diseases

Australian generic drugmakers welcome IP law to encourage R&D investment


Members of Australia’s Generic Medicines Industry Association (GMiA) have strongly welcomed the…


Chile remains on USTR Priority Watch list


The Office of the United States Trade Representative (USTR) released its annual Special 301 Report on…

GenericsLegalNorth AmericaPatentsPharmaceuticalSouth America

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA


Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Teva to buy Japanese generic drugmaker Taiyo?


According to Japan’s leading financial newspaper, The Nikkei, Israeli generics drug giant Teva Pharmaceutical…

Asia-PacificGenericsMergers & AcquisitionsTaiyo PharmaTeva Pharmaceutical Industries

Mylan's 1st-qtr 2011 adjusted diluted EPS up 22%, in line with forecasts


US generics group Mylan (Nasdaq: MYL) reported that total revenues for the quarter ended March 31, 2011…

FinancialGenericsMylan Laboratories

European Commission opens investigation against Cephalon and Teva


The European Commission has opened a formal antitrust investigation to assess whether an agreement between…

CephalonEuropeGenericsLegalTeva Pharmaceutical Industries

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body


The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

Generic drug sales in Brazil leapt 53% in 2010; double-digit growth forecast the next two years


In Brazil, sales last year of generic drugs - which are nearly identical reproductions of off-patent…

GenericsMarkets & MarketingPatentsSouth America

Watson 1st-qtr 2011 net revenue Increases 2.3% to $877 million


USA-based generics and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) reported net revenue of…

FinancialGenericsPharmaceuticalWatson Pharmaceuticals

1240 to 1264 of 1269 results

Back to top